Christian Lübbert is Managing Director of amofor GmbH, a company specializing in predictive, physics-based modeling for pharmaceutical formulation development. With a background in chemical engineering, his work focuses on the application of thermodynamic and molecular modeling approaches—particularly PC-SAFT—to enable a deeper mechanistic understanding of drug delivery systems.

He has extensive experience in the development of amorphous solid dispersions (ASDs), where he combines in-silico methods with experimental validation to predict stability, solubility, and performance of complex formulations. His work aims to replace empirical trial-and-error approaches with predictive, data-efficient development strategies.

At amofor, Christian leads the development of advanced in-silico simulation platforms that integrate molecular interactions, transport phenomena, and formulation physics to support the design and optimization of drug products. His current focus includes extending these approaches toward the prediction of biological performance and pharmacokinetics, bridging the gap between formulation design and in vivo outcomes.